Actively Recruiting
Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China
Led by University of Toronto · Updated on 2024-12-06
72000
Participants Needed
1
Research Sites
179 weeks
Total Duration
On this page
Sponsors
U
University of Toronto
Lead Sponsor
G
Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to find out if using mobile vans with advanced technology can help reduce tuberculosis (TB) in rural Guangxi, China. The study will also examine how practical and cost-effective this approach is. The main questions it aims to answer are: 1) Does this new screening method lower the number of TB cases among high-risk groups? and 2) Is this method practical and acceptable for communities and healthcare workers? Participants in the study will: 1) undergo TB screening with mobile vans that use artificial intelligence (AI) to read chest X-rays, 2) answer a short questionnaire about their symptoms and health history, and 3) provide sputum samples for GeneXpert testing if needed. Some communities will receive the new screening method, while others will continue with usual care. Researchers will compare TB rates in the two groups over three years to see if the new approach works better for TB control. If successful, this method could be used to improve TB control in other areas.
CONDITIONS
Official Title
Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All residents aged 65 and above
- Residents aged 15 to 64 who have been previously treated for TB or have been close contacts of a TB patient diagnosed within the last three years
- Residents aged 15 to 64 who have been diagnosed with diabetes, are HIV positive, or have worked as miners
- Signed consent form
You will not qualify if you...
- Residents who refuse to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Nanning, Guangxi, China, 530000
Actively Recruiting
Research Team
D
Dabin Liang, PhD
CONTACT
X
Xiaoyan Liang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here